Cargando…

Studies on the Anticancer and Antioxidant Activities of Resveratrol and Long-Chain Fatty Acid Esters

Resveratrol (RES) is gaining recognition as a natural bioactive compound. To expand the possible applications of RES with its enhanced bioactivity as well as to increase the health benefits of long-chain fatty acids, a lipophilization process of RES was performed using three fatty acids: palmitic ac...

Descripción completa

Detalles Bibliográficos
Autores principales: Szczepańska, Patrycja, Rychlicka, Magdalena, Groborz, Sylwia, Kruszyńska, Angelika, Ledesma-Amaro, Rodrigo, Rapak, Andrzej, Gliszczyńska, Anna, Lazar, Zbigniew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10139102/
https://www.ncbi.nlm.nih.gov/pubmed/37108328
http://dx.doi.org/10.3390/ijms24087167
_version_ 1785032865223802880
author Szczepańska, Patrycja
Rychlicka, Magdalena
Groborz, Sylwia
Kruszyńska, Angelika
Ledesma-Amaro, Rodrigo
Rapak, Andrzej
Gliszczyńska, Anna
Lazar, Zbigniew
author_facet Szczepańska, Patrycja
Rychlicka, Magdalena
Groborz, Sylwia
Kruszyńska, Angelika
Ledesma-Amaro, Rodrigo
Rapak, Andrzej
Gliszczyńska, Anna
Lazar, Zbigniew
author_sort Szczepańska, Patrycja
collection PubMed
description Resveratrol (RES) is gaining recognition as a natural bioactive compound. To expand the possible applications of RES with its enhanced bioactivity as well as to increase the health benefits of long-chain fatty acids, a lipophilization process of RES was performed using three fatty acids: palmitic acid (PA), oleic acid (OA), and conjugated linoleic acid (CLA). The obtained mono-, di-, and tri-esters of RES were evaluated for their anticancer and antioxidant properties against lung carcinoma (A549), colorectal adenocarcinoma (HT29), and pancreatic ductal adenocarcinoma (BxPC3) cell lines. Human fibroblast (BJ) cells were used as a control. Several parameters were investigated: cell viability and apoptosis, including the expression of major pro- and anti-apoptotic markers, as well as the expression of superoxide dismutase, a key enzyme of the body’s antioxidant barrier. Three of the obtained esters: mono-RES-OA, mono-RES-CLA, and tri-RES-PA, which significantly reduced the tumor cell viability up to 23%, at concentrations 25, 10, 50 μg/mL, respectively, turned out to be particularly interesting. The above-mentioned resveratrol derivatives similarly increased the tumor cells’ apoptosis by modifying their caspase activity of pro-apoptotic pathways (p21, p53, and Bax). Moreover, among the mentioned esters, mono-RES-OA induced apoptosis of the analyzed cell lines most strongly, reducing the number of viable cells up to 48% for HT29 cells versus 36% for pure RES. Furthermore, the selected esters exhibited antioxidant properties towards the normal BJ cell line by regulating the expression of major pro-antioxidant genes (superoxide dismutases—SOD1 and SOD2) without the effect on their expression in the tumor, and therefore reducing the defense of cancer cells against increased oxidative stress induced by high ROS accumulation. The obtained results indicate that the esters of RES and long-chain fatty acids allow enhancement of their biological activity. The RES derivatives have the potential for being applied in cancer prevention and treatment, as well as for oxidative stress suppression.
format Online
Article
Text
id pubmed-10139102
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-101391022023-04-28 Studies on the Anticancer and Antioxidant Activities of Resveratrol and Long-Chain Fatty Acid Esters Szczepańska, Patrycja Rychlicka, Magdalena Groborz, Sylwia Kruszyńska, Angelika Ledesma-Amaro, Rodrigo Rapak, Andrzej Gliszczyńska, Anna Lazar, Zbigniew Int J Mol Sci Article Resveratrol (RES) is gaining recognition as a natural bioactive compound. To expand the possible applications of RES with its enhanced bioactivity as well as to increase the health benefits of long-chain fatty acids, a lipophilization process of RES was performed using three fatty acids: palmitic acid (PA), oleic acid (OA), and conjugated linoleic acid (CLA). The obtained mono-, di-, and tri-esters of RES were evaluated for their anticancer and antioxidant properties against lung carcinoma (A549), colorectal adenocarcinoma (HT29), and pancreatic ductal adenocarcinoma (BxPC3) cell lines. Human fibroblast (BJ) cells were used as a control. Several parameters were investigated: cell viability and apoptosis, including the expression of major pro- and anti-apoptotic markers, as well as the expression of superoxide dismutase, a key enzyme of the body’s antioxidant barrier. Three of the obtained esters: mono-RES-OA, mono-RES-CLA, and tri-RES-PA, which significantly reduced the tumor cell viability up to 23%, at concentrations 25, 10, 50 μg/mL, respectively, turned out to be particularly interesting. The above-mentioned resveratrol derivatives similarly increased the tumor cells’ apoptosis by modifying their caspase activity of pro-apoptotic pathways (p21, p53, and Bax). Moreover, among the mentioned esters, mono-RES-OA induced apoptosis of the analyzed cell lines most strongly, reducing the number of viable cells up to 48% for HT29 cells versus 36% for pure RES. Furthermore, the selected esters exhibited antioxidant properties towards the normal BJ cell line by regulating the expression of major pro-antioxidant genes (superoxide dismutases—SOD1 and SOD2) without the effect on their expression in the tumor, and therefore reducing the defense of cancer cells against increased oxidative stress induced by high ROS accumulation. The obtained results indicate that the esters of RES and long-chain fatty acids allow enhancement of their biological activity. The RES derivatives have the potential for being applied in cancer prevention and treatment, as well as for oxidative stress suppression. MDPI 2023-04-12 /pmc/articles/PMC10139102/ /pubmed/37108328 http://dx.doi.org/10.3390/ijms24087167 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Szczepańska, Patrycja
Rychlicka, Magdalena
Groborz, Sylwia
Kruszyńska, Angelika
Ledesma-Amaro, Rodrigo
Rapak, Andrzej
Gliszczyńska, Anna
Lazar, Zbigniew
Studies on the Anticancer and Antioxidant Activities of Resveratrol and Long-Chain Fatty Acid Esters
title Studies on the Anticancer and Antioxidant Activities of Resveratrol and Long-Chain Fatty Acid Esters
title_full Studies on the Anticancer and Antioxidant Activities of Resveratrol and Long-Chain Fatty Acid Esters
title_fullStr Studies on the Anticancer and Antioxidant Activities of Resveratrol and Long-Chain Fatty Acid Esters
title_full_unstemmed Studies on the Anticancer and Antioxidant Activities of Resveratrol and Long-Chain Fatty Acid Esters
title_short Studies on the Anticancer and Antioxidant Activities of Resveratrol and Long-Chain Fatty Acid Esters
title_sort studies on the anticancer and antioxidant activities of resveratrol and long-chain fatty acid esters
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10139102/
https://www.ncbi.nlm.nih.gov/pubmed/37108328
http://dx.doi.org/10.3390/ijms24087167
work_keys_str_mv AT szczepanskapatrycja studiesontheanticancerandantioxidantactivitiesofresveratrolandlongchainfattyacidesters
AT rychlickamagdalena studiesontheanticancerandantioxidantactivitiesofresveratrolandlongchainfattyacidesters
AT groborzsylwia studiesontheanticancerandantioxidantactivitiesofresveratrolandlongchainfattyacidesters
AT kruszynskaangelika studiesontheanticancerandantioxidantactivitiesofresveratrolandlongchainfattyacidesters
AT ledesmaamarorodrigo studiesontheanticancerandantioxidantactivitiesofresveratrolandlongchainfattyacidesters
AT rapakandrzej studiesontheanticancerandantioxidantactivitiesofresveratrolandlongchainfattyacidesters
AT gliszczynskaanna studiesontheanticancerandantioxidantactivitiesofresveratrolandlongchainfattyacidesters
AT lazarzbigniew studiesontheanticancerandantioxidantactivitiesofresveratrolandlongchainfattyacidesters